| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |